ClimAIr: AI to Assess the Impact of Pollution and Climate on Respiratory Health in Europe
NCT07107009 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1906
Last updated 2025-12-17
Summary
The ClimAIr project will expand the evidence-based understanding of climate change, air pollution, and non-communicable respiratory diseases by using Artificial Intelligence (AI) tools. It will gather data on greenhouse gases levels and disaster risks, information on serious air pollutants and respiratory diseases' prevalence. The AI powered tools will be employed to generate better intervention methods and improve public health outcomes.
Federated Learning (FL) will be used to develop AI models to protect patients' privacy. By raising public awareness and delivering the ClimAIr tool - specifically designed to health workers, urban planners and policy makers - the project aims to influence policy decisions, promote healthier environments, and reduce respiratory diseases in Europe, which will be tested and validated the ClimAIr tool in specific municipalities that are part of the project. ClimAIr draws on a consortium of 21 partners from 15 European countries, including carefully selected health centres across Europe - in Spain, Luxembourg, Ukraine, Italy, France, Germany, Greece, Romania and Poland - focused on respiratory diseases, which will provide disease data and explore metabolic routes of the studied contaminants/diseases. ClimAIr is composed of an interdisciplinary team formed by research centres, ethical AI and modelling experts, SSH specialists, municipal governance, and a Communication \& Dissemination (C\&D) expert team dedicated to achieving and spread the results of the project.
Conditions
- Allergic Rhinitis
- Asthma
Sponsors & Collaborators
-
Theramed Healthcare SRL (Romania)
collaborator UNKNOWN -
Centre Hospitalier Universitaire de Toulouse, FRANCE
collaborator UNKNOWN -
Charite-Universitaetsmedizin Berlin (Germany)
collaborator UNKNOWN -
Aristotelio Panepistimio Thessalonikis (Greece)
collaborator UNKNOWN -
Uniwersytet Medyczny w Lodzi (Poland)
collaborator UNKNOWN -
Universita degli Studi di Milano (Italy)
collaborator UNKNOWN -
Bukovinian State Medical University (Ukraine)
collaborator UNKNOWN -
Luxembourg Institute of Health (Luxembourg)
collaborator UNKNOWN -
Andaluz Health Service
collaborator OTHER_GOV -
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
lead OTHER
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-31
- Primary Completion
- 2026-06-30
- Completion
- 2027-12-31
More Related Trials
-
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
NCT05270278 ·Status: COMPLETED
-
Study of Physiopathological Mechanisms and Results of Treatment With Bronchial Thermoplasty in Severe Asthma
NCT01974921 ·Status: UNKNOWN ·Phase: NA
-
Estimating the Use of Resources and the Costs of Treating Patients With Asthma in the Autonomous Community of Valencia
NCT01114906 ·Status: COMPLETED
-
Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System
NCT06389058 ·Status: ACTIVE_NOT_RECRUITING
-
GeoAsma: Pilot and Evaluation of a Clinical Decision Support System and a Mobile App for the Management of Asthma Patients.
NCT05639101 ·Status: UNKNOWN ·Phase: NA
-
Bronchial Thermoplasty Global Registry
NCT02104856 ·Status: COMPLETED
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING
-
Study of Indoor Air Pollutants and Their Impact in Childhood Health and Wellbeing
NCT05997784 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers in Exhaled Breath From Asthmatic Patients
NCT00635271 ·Status: TERMINATED
-
Experience of Biologic Treatments for Severe Asthma: a Survey
NCT06903780 ·Status: RECRUITING
-
Towards an Algorithmic Approach to Asthma Management: Collaborative Definition of Algorithm Objectives With Families
NCT05064579 ·Status: COMPLETED
-
Remote Monitoring of Asthma in Children and Young People
NCT07129616 ·Status: RECRUITING
-
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
NCT01589198 ·Status: COMPLETED
-
LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction
NCT01583296 ·Status: COMPLETED ·Phase: NA
-
Asthma Biomarker Study
NCT02392481 ·Status: COMPLETED
-
China Alair System Registry Study-CARE Study
NCT02206269 ·Status: UNKNOWN
-
Prevalence of Severe Asthma in Spanish Hospitals
NCT03137043 ·Status: COMPLETED
-
Symbicort SMART (Symbicort Maintenance And Reliever Therapy)
NCT00523679 ·Status: COMPLETED
-
Prospective Study of the Feedback From an Adherence Monitor on Asthma Control
NCT01529697 ·Status: COMPLETED ·Phase: NA
-
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
NCT04714567 ·Status: UNKNOWN
-
Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma
NCT06364527 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
NCT02537691 ·Status: COMPLETED ·Phase: PHASE4
-
Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.
NCT02028637 ·Status: COMPLETED ·Phase: NA
-
Evidence Driven Indoor Air Quality Improvement
NCT05992389 ·Status: UNKNOWN